Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Pulse Field Ablation on Hemolysis Markers: A Single-Center Experience.

Journal of cardiovascular electrophysiology·2026
Same author

Cardiac screening in adolescents: Insights from a 15-year Student Heart Check program.

Heart rhythm O2·2026
Same author

Comparing the risk of heart failure in patients with inflammatory bowel disease treated with infliximab versus adalimumab: a retrospective cohort study using a national database.

Proceedings (Baylor University. Medical Center)·2026
Same author

Increased cardiac complications but no change in obstetric outcomes among pregnant women with atrial fibrillation.

American journal of obstetrics & gynecology MFM·2026
Same author

Impact of Preoperative Echocardiogram Screening on Intraoperative Cardiac Events in Patients in Rural Appalachia.

The American journal of cardiology·2026
Same author

Impact of hiatal hernia on clinical outcomes of rhythm control of atrial fibrillation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026

Related Experiment Video

Updated: Jun 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Atrial Fibrillation Risk Management and Emerging Therapies.

Megan Vaughan1, Banveet Kaur2, Nishaki K Mehta3

  • 1Department of Internal Medicine, West Virginia University School of Medicine, Morgantown, WV 26506, USA.

Journal of Clinical Medicine
|June 26, 2026
PubMed
Summary

Atrial fibrillation (AF) is a common heart rhythm disorder. Effective management involves addressing risk factors, comorbid conditions, and choosing personalized treatments like medication or left atrial appendage occlusion.

Keywords:
antiarrhythmic drugsanticoagulationatrial fibrillationcatheter ablationleft atrial appendage occlusion

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Experiment Videos

Last Updated: Jun 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) is the most prevalent tachyarrhythmia globally, with rising incidence linked to aging populations and cardiovascular disease.
  • A complex interplay exists between cardiac remodeling and AF, suggesting that managing both can lead to condition reversal.

Purpose of the Study:

  • To review risk factors and treatments for AF, focusing on how comorbid conditions impact treatment outcomes.
  • To explore current and emerging therapeutic strategies for AF management.

Main Methods:

  • Comprehensive review of observational cohort studies, systematic reviews, meta-analyses, and randomized controlled trials (RCTs).
  • Analysis of pharmacological strategies (rate vs. rhythm control) and interventional approaches like left atrial appendage (LAA) occlusion.

Main Results:

  • Modifiable risk factors for AF are numerous; delayed treatment can render them unmodifiable.
  • Optimal AF treatment requires a flexible strategy considering patient comorbidities, medication factors, and preferences.
  • Left atrial appendage occlusion devices demonstrate safety and efficacy, though bleeding risk and anticoagulation require careful consideration.

Conclusions:

  • Aggressive management of AF and associated cardiovascular disease may reverse pathological changes.
  • Emerging therapies, including novel drug combinations, neuromodulation, and GLP-1 agonists, show promise for AF treatment and metabolic disease reduction.